Changes in lipoprotein kinetics during therapy with fenofibrate and other fibric acid derivatives-Reference-Cited by-同舟云学术

Changes in lipoprotein kinetics during therapy with fenofibrate and other fibric acid derivatives

Published:1987-11 Issue:5 Volume:83 Page:66-70
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Ginsberg Henry N.

Publisher

Elsevier BV

Subject

General Medicine

Reference9 articles.

1. Transport kinetics of plasma free fatty acids, very low density lipoprotein triglycerides and apoprotein in patients with hypertriglyceridemia;Kissebah,1976

2. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglyceride in man;Kesaniemi;JAMA,1984

3. Apolipoprotein A and B (Sf 100–400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects;Shepherd;J Clin Invest,1984

4. Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjects;Packard;J Lipid Res,1986

5. Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinemic subjects;Stewart;Atheroslcerosis,1982

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk;New England Journal of Medicine;2022-11-24

2. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society;European Heart Journal;2021-09-02

3. Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease;Clinical Chemistry;2020-11-22

4. Causes and Consequences of Hypertriglyceridemia;Frontiers in Endocrinology;2020-05-14

5. Isotopic Tracers for the Measurement of Metabolic Flux Rates;Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease;2019